questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Glycoprotéines membranaires
Protéines liées au GPI
Carbonic anhydrase-IV
Carbonic anhydrase-IV : Questions médicales fréquentes
Termes MeSH sélectionnés :
Platelet Glycoprotein GPIIb-IIIa Complex
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Carbonic anhydrase-IV : Questions médicales les plus fréquentes",
"headline": "Carbonic anhydrase-IV : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Carbonic anhydrase-IV : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-15",
"dateModified": "2025-04-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Carbonic anhydrase-IV"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines liées au GPI",
"url": "https://questionsmedicales.fr/mesh/D058851",
"about": {
"@type": "MedicalCondition",
"name": "Protéines liées au GPI",
"code": {
"@type": "MedicalCode",
"code": "D058851",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.550.418"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Carbonic anhydrase-IV",
"alternateName": "Carbonic Anhydrase IV",
"code": {
"@type": "MedicalCode",
"code": "D030741",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Claudiu T Supuran",
"url": "https://questionsmedicales.fr/author/Claudiu%20T%20Supuran",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmaceutical and Nutraceutical Sciences Section, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy."
}
},
{
"@type": "Person",
"name": "Andrea Angeli",
"url": "https://questionsmedicales.fr/author/Andrea%20Angeli",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurosciences, Psychology, Drug Research and Child Health, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, Italy."
}
},
{
"@type": "Person",
"name": "Alessio Nocentini",
"url": "https://questionsmedicales.fr/author/Alessio%20Nocentini",
"affiliation": {
"@type": "Organization",
"name": "Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Pharmaceutical and Nutraceutical Sciences Section, University of Florence, Via Ugo Schiff 6, 50019 Florence, Italy."
}
},
{
"@type": "Person",
"name": "Clemente Capasso",
"url": "https://questionsmedicales.fr/author/Clemente%20Capasso",
"affiliation": {
"@type": "Organization",
"name": "Istituto di Bioscienze e Biorisorse - Consiglio Nazionale delle Ricerche CNR, Via P: Castellino 111, 80131, Naples, Italy."
}
},
{
"@type": "Person",
"name": "Marta Ferraroni",
"url": "https://questionsmedicales.fr/author/Marta%20Ferraroni",
"affiliation": {
"@type": "Organization",
"name": "University of Florence, Department of Chemistry, via della Lastruccia, 50019 Sesto Fiorentino, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Repeated platelet activation and the potential of previously activated platelets to contribute to thrombus formation.",
"datePublished": "2023-01-14",
"url": "https://questionsmedicales.fr/article/36754678",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtha.2023.01.006"
}
},
{
"@type": "ScholarlyArticle",
"name": "Management of Abdominal Aortic Aneurysm Surgery in Glanzmann's Thrombasthenia Patients with Anti-GPIIb-IIIa Antibodies: A Case Report.",
"datePublished": "2024-09-30",
"url": "https://questionsmedicales.fr/article/39407899",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/jcm13195839"
}
},
{
"@type": "ScholarlyArticle",
"name": "Increased platelet activation and lower platelet-monocyte aggregates in COVID-19 patients with severe pneumonia.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36888618",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0282785"
}
},
{
"@type": "ScholarlyArticle",
"name": "Stoichiometry and architecture of the platelet membrane complex glycoprotein Ib-IX-V.",
"datePublished": "2023-03-22",
"url": "https://questionsmedicales.fr/article/36942505",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/hsz-2022-0227"
}
},
{
"@type": "ScholarlyArticle",
"name": "SHIP1 Controls Internal Platelet Contraction and α",
"datePublished": "2023-01-04",
"url": "https://questionsmedicales.fr/article/36674478",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24020958"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glycoprotéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008562"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines liées au GPI",
"item": "https://questionsmedicales.fr/mesh/D058851"
},
{
"@type": "ListItem",
"position": 7,
"name": "Carbonic anhydrase-IV",
"item": "https://questionsmedicales.fr/mesh/D030741"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Carbonic anhydrase-IV - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Carbonic anhydrase-IV",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Carbonic anhydrase-IV",
"description": "Comment diagnostiquer une déficience en anhydrase carbonique IV ?\nQuels examens sont utilisés pour évaluer l'activité de l'enzyme ?\nQuels symptômes peuvent indiquer un problème avec l'enzyme ?\nY a-t-il des marqueurs biologiques spécifiques ?\nPeut-on utiliser l'imagerie pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Carbonic anhydrase-IV",
"description": "Quels sont les symptômes d'une déficience en anhydrase carbonique IV ?\nComment se manifestent les troubles respiratoires ?\nY a-t-il des symptômes neurologiques associés ?\nLes calculs rénaux sont-ils un symptôme courant ?\nPeut-on observer des symptômes digestifs ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Carbonic anhydrase-IV",
"description": "Peut-on prévenir la déficience en anhydrase carbonique IV ?\nY a-t-il des mesures préventives pour les calculs rénaux ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nDes conseils diététiques peuvent-ils prévenir les symptômes ?\nLes activités physiques sont-elles bénéfiques ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Carbonic anhydrase-IV",
"description": "Quels traitements sont disponibles pour la déficience ?\nLa thérapie génique est-elle une option ?\nComment gérer les symptômes respiratoires ?\nY a-t-il des médicaments spécifiques à éviter ?\nLes changements alimentaires sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Carbonic anhydrase-IV",
"description": "Quelles complications peuvent survenir avec cette déficience ?\nLes troubles respiratoires peuvent-ils s'aggraver ?\nY a-t-il un risque accru de déshydratation ?\nLes complications neurologiques sont-elles possibles ?\nComment les complications sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Carbonic anhydrase-IV",
"description": "Quels sont les facteurs de risque pour cette déficience ?\nL'âge joue-t-il un rôle dans le risque ?\nLes maladies rénales augmentent-elles le risque ?\nY a-t-il des facteurs environnementaux à considérer ?\nLes habitudes alimentaires peuvent-elles affecter le risque ?",
"url": "https://questionsmedicales.fr/mesh/D030741?mesh_terms=Platelet+Glycoprotein+GPIIb-IIIa+Complex&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en anhydrase carbonique IV ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses sanguines peuvent confirmer la déficience."
}
},
{
"@type": "Question",
"name": "Quels examens sont utilisés pour évaluer l'activité de l'enzyme ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques dans des échantillons de sang ou de tissus sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec l'enzyme ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la déshydratation, des troubles respiratoires ou des calculs rénaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques spécifiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux de bicarbonate dans le sang peuvent indiquer un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie peut aider à évaluer les complications, mais n'est pas spécifique au diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en anhydrase carbonique IV ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, déshydratation, et troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par une respiration rapide ou des difficultés à respirer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête et des troubles de la concentration peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les calculs rénaux sont-ils un symptôme courant ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la formation de calculs rénaux est fréquente en cas de déficience."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes digestifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées et des vomissements peuvent également être présents."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la déficience en anhydrase carbonique IV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un diagnostic précoce peut aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les calculs rénaux ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Boire beaucoup d'eau et réduire l'apport en sel peut aider à prévenir les calculs."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque."
}
},
{
"@type": "Question",
"name": "Des conseils diététiques peuvent-ils prévenir les symptômes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut réduire les symptômes associés."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles bénéfiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activité physique modérée peut améliorer la santé générale et le bien-être."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la déficience ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des suppléments de bicarbonate et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore disponible pour cette condition."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes respiratoires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des bronchodilatateurs peuvent être prescrits pour améliorer la respiration."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques à éviter ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains diurétiques peuvent aggraver les symptômes et doivent être évités."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires sont-ils recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en liquides et faible en sodium est souvent conseillée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec cette déficience ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'acidose métabolique et des troubles rénaux peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires peuvent-ils s'aggraver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans traitement, les troubles respiratoires peuvent devenir graves."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de déshydratation ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent être plus susceptibles de souffrir de déshydratation."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques comme des convulsions peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour cette déficience ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de déficience peuvent se manifester dès l'enfance."
}
},
{
"@type": "Question",
"name": "Les maladies rénales augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies rénales préexistantes peuvent exacerber les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs environnementaux à considérer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines expositions environnementales peuvent influencer le risque de déficience."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires peuvent-elles affecter le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut contribuer à des complications."
}
}
]
}
]
}
Especially in disease conditions, platelets can encounter activating agents in circulation....
To investigate the extent to which previously activated platelets can be reactivated and whether in-and reactivation applies to different aspects of platelet activation and thrombus formation....
Short-and long-term effects of glycoprotein VI (GPVI) and G protein-coupled receptor (GPCR) stimulation on platelet activation and aggregation potential were compared via flow cytometry and plate-base...
After 30 minutes of stimulation with thrombin receptor activator peptide 6 (TRAP6) or adenosine diphosphate (ADP), platelets secondarily decreased in PAC-1 binding and were less able to aggregate. The...
This work emphasizes that prior platelet activation can be reversed, whereafter platelets can be reactivated through a different receptor. Reversed, previously activated platelets can contribute to th...
Glanzmann's thrombasthenia (GT) is a rare autosomal recessive disorder of platelet function. The frequent occurrence of alloimmunization due to repeated platelet transfusions is the major complication...
The increased procoagulant platelets and platelet activation are associated with thrombosis in COVID-19. In this study, we investigated platelet activation in COVID-19 patients and their association w...
COVID-19 patients were classified into three severity groups: no pneumonia, mild-to-moderate pneumonia, and severe pneumonia. The expression of P-selectin and activated glycoprotein (aGP) IIb/IIIa on ...
P-selectin expression, platelet-neutrophil, platelet-lymphocyte, and platelet-monocyte aggregates were higher in COVID-19 patients than in uninfected control individuals. In contrast, aGPIIb/IIIa expr...
COVID-19 patients have higher platelet-leukocyte aggregates and P-selectin expression than controls, indicating increased platelet activation. Compared within patient groups, platelet-monocyte aggrega...
Glycoprotein (GP) Ib-IX-V is the second most abundant platelet receptor for thrombin and other ligands crucial for hemostasis and thrombosis. Its activity is involved in platelet adhesion to vascular ...
The Src homology 2 domain-containing inositol 5-phosphatase 1 (SHIP1) is known to dephosphorylate PtdIns(3,4,5)P...
Monocyte-platelet aggregates (MPAs) represent the crossroads between thrombosis and inflammation, and targeting this axis may suppress thromboinflammation. While antiplatelet therapy (APT) reduces pla...
To analyze the effect of platelets on monocyte activation and APT on MPA and platelet-induced monocyte activation....
Agonist-stimulated whole blood was incubated in the presence of P-selectin, PSGL1, PAR1, P2Y...
Consistent with a proinflammatory platelet effector role, MPAs were increased in patients with COVID-19. RNA-Seq revealed a thromboinflammatory monocyte transcriptome upon incubation with platelets. M...
Integrins are heterodimeric transmembrane receptors composed of α and β chains, with an N-terminal extracellular domain forming a globular head corresponding to the ligand binding site. Integrins regu...
Deep vein thrombosis (DVT) is a prevalent cardiovascular condition. Endothelial-derived extracellular vesicles (EVs) may play a crucial role in platelet-dependent DVT development via platelet activati...
The interaction between protein disulfide isomerase (PDI) and glucose-regulated protein 94 (GRP94) was founded by molecular docking. Inferior vena cava stasis-induced mice received PDI and GRP94 inhib...
In a DVT mouse model, platelets enhance venous thrombus formation in a coagulation-independent manner, instead, platelet activation and the length of the thrombus are related to PDI and GRP94 activity...
Endothelial-derived EVs carrying PDI induce DVT via interplay with GRP94 and GPIIb/IIIa in platelets. These findings emphasize the significance of platelets in DVT formation, and PDI may be a suitable...
Coumarin was first discovered in Tonka bean and then widely in other plants. Coumarin has an anticoagulant effect, and its derivative, warfarin, is a vitamin K analogue that inhibits the synthesis of ...
Platelet endothelial aggregation receptor 1 (PEAR1) is a single-transmembrane orphan receptor primarily expressed on platelets and endothelial cells. Genetic variants of PEAR1 have repeatedly and inde...
We have identified sulfated fucoidans and their mimetics as ligands for PEAR1 and proposed that its endogenous ligand is a sulfated proteoglycan. The aim of this study was to test this hypothesis....
A heparin proteoglycan-mimetic (HPGM) was created by linking unfractionated heparin (UFH) to albumin. The ability of the HPGM, UFH and selectively desulfated heparins to stimulate platelet aggregation...
We show that HPGM, heparin conjugated to an albumin protein core, stimulates aggregation and phosphorylation of PEAR1 in washed platelets. Platelet aggregation was abolished by an anti-PEAR1 nanobody,...
Our findings reveal that PEAR1 is a receptor for heparin and HPGM and that PI3Kβ is a key signaling molecule downstream of PEAR1 in platelets. These findings may have important implications for our un...